Evidence map›Paper›PMID 24778621›Full record

ArticleFrontiers in psychiatry2014

Drug Injection to Sites other than Arm: A Study of Iranian Heroin Injectors.

Mehrdad Karimi, Hafez Ghaheri, Shervin Assari, Khodabakhsh Ahmadi, Maryam Moghani Lankarani, Reza Moghani Lankarani, Hooman Narenjiha, Hassan Rafiey, Mahmood Tavakoli, Firoozeh Jafari

Open access · goldAbstract read
In one paragraph

Article in Frontiers in psychiatry, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
2.1field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 23 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 2 countries.

Mehrdad KarimiShahrekord University of Medical Sciences , Tehran , Iran.
Hafez GhaheriIsfahan University of Medical Sciences , Isfahan , Iran.
Shervin AssariDepartment of Health Behavior and Health Education, University of Michigan School of Public Health , Ann Arbor, MI , USA.
Khodabakhsh AhmadiBehavioral Sciences Research Center, Baqiyatallah Medical Sciences University , Tehran , Iran.
Maryam Moghani LankaraniUniversal Network for Health Information Dissemination and Exchange , Tehran , Iran.
Reza Moghani LankaraniMedicine and Health Promotion Institute , Tehran , Iran.
Hooman NarenjihaSubstance Abuse and Dependence Research Center, University of Social Welfare and Rehabilitation Sciences , Tehran , Iran.
Hassan RafieySubstance Abuse and Dependence Research Center, University of Social Welfare and Rehabilitation Sciences , Tehran , Iran.
Mahmood TavakoliSubstance Abuse and Dependence Research Center, University of Social Welfare and Rehabilitation Sciences , Tehran , Iran.
Firoozeh JafariSubstance Abuse and Dependence Research Center, University of Social Welfare and Rehabilitation Sciences , Tehran , Iran.
Baqiyatallah University of Medical Sciences · IRIsfahan University of Medical Sciences · IRUniversity of Michigan–Ann Arbor · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

For almost all injecting drug users (IDUs), the first site of injection is the arm. Years after injection, IDUs may shift to using other sites for intravenous (IV) access. Although injection to sites other than the arm is associated with higher risks, literature is limited regarding this behavior. We aimed to determine the prevalence and associated factors of using IV access points other than the arm among a national sample of IDUs in Iran. Data came from the National Drug Dependence Survey, 2007, which had enrolled 863 IDUs with at least one daily injection. Data on socio-demographics, pattern of drug use, and injection-related behaviors were entered into a logistic regression to determine predictors of injection to sites other than the arm. From all participants, 54.8% reported current injection sites in areas other than the arm. The other injection sites were the femoral venous sinus (17.0%), followed by the groin (14.5%) and neck (11.5%). Logistic regression revealed that living alone [odds ratio (OR) = 1.789, 95% confidence interval (CI) = 1.218-2.629], being Sunni (OR = 3.475, 95% CI = 1.775-6.801), having higher family income (OR = 1.002, 95% CI = 1.001-1.003), higher age at first drug use (OR = 1.039, 95% CI = 1.009-1.069), longer injection duration (OR = 1.071, 95% CI = 1.041-1.102), and more injection frequency (OR = 1.255, 95% CI = 1.072-1.471) were associated with higher likelihood of using injection sites other than the arm. Using sites other than the arm for IV injection is linked to socio-demographics, drug use data, and injection-related characteristics that can be used by policy makers. This information can be used for harm reduction planning.

Indexed as

armdrug injectionheroininjection sitesIran

Identifiers

PMID24778621
PMCPMC3985009
OpenAlexW2085503199

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.